# PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/PMVP/pmv-pharmaceuticals-to-participate-at-upcoming-investor-conferences
Ticker: PMVP
Company: PMV Pharmaceuticals
Source: PMV Pharmaceuticals
Published: 2025-05-23 20:05 EST
Original Source URL: https://ir.pmvpharma.com
## Summary

PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H.

## Article Body
PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H.
## Recent Company News
- 2026-05-12 12:00 EST — [PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights](https://biopharmsignal.com/news/PMVP/pmv-pharmaceuticals-reports-first-quarter-2026-financial-results-and-corporate-highlights) — Source: PMV Pharmaceuticals
- 2026-04-22 12:00 EST — [PMV Pharmaceuticals Announces Board Chair Transition](https://biopharmsignal.com/news/PMVP/pmv-pharmaceuticals-announces-board-chair-transition) — Source: PMV Pharmaceuticals
- 2026-03-06 13:00 EST — [PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights](https://biopharmsignal.com/news/PMVP/pmv-pharmaceuticals-reports-full-year-2025-financial-results-and-corporate-highlights) — Source: PMV Pharmaceuticals
- 2026-02-26 13:00 EST — [New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors](https://biopharmsignal.com/news/PMVP/new-england-journal-of-medicine-publishes-first-in-human-rezatapopt-data-showing-selective-reactivation-of-mutant-p53-in-advanced-solid-tumors) — Source: PMV Pharmaceuticals
- 2025-11-12 13:01 EST — [PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights](https://biopharmsignal.com/news/PMVP/pmv-pharmaceuticals-reports-third-quarter-2025-financial-results-and-corporate-highlights) — Source: PMV Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)